Inotek Pharma (ITEK) Reports Q1 Loss of $0.38

Inotek Pharma (NASDAQ: ITEK) reported Q1 EPS of ($0.38), versus ($0.21) reported last year.

For earnings history and earnings-related data on Inotek Pharma (ITEK) click here.

You May Also Be Interested In

• Piper Sandler sees Google TPU sales hitting $104BN by 2028
• AIxCrypto signs non-binding deal to acquire Faraday Future robotics unit
• Jefferies Financial stock slips 3% as Fixed Income, Asset Management revenues fall